Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State of the Art Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State of the Art Review

Published:2021-10-13 Issue: Volume: Page:
ISSN:0257-2753
Container-title:Digestive Diseases
language:en
Short-container-title:Dig Dis

Author:

Reiter Florian P.,Ben Khaled Najib^ORCID,Ye Liangtao,Zhang Changhua,Seidensticker Max,op den Winkel Mark^ORCID,Denk Gerald,Geier Andreas,De Toni Enrico N.

Publisher

S. Karger AG

Subject

Gastroenterology,General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events;JHEP Reports;2024-06

2. Gene trail of polarized M2 macrophage decodes tumor heterogeneity and recommendation for therapy of hepatocellular carcinoma;2024-04-09

3. GANT61, an inhibitor of Gli1, inhibits the proliferation and migration of hepatocellular carcinoma cells;Journal of Investigative Medicine;2023-10-09

4. Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations;Zeitschrift für Gastroenterologie;2022-11-15

5. Comparative Response of HCC Cells to TKIs: Modified in vitro Testing and Descriptive Expression Analysis;Journal of Hepatocellular Carcinoma;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP